The global drug and gene delivery devices market was valued at USD 670.00 Million in 2024, driven by the increasing prevalence of chronic diseases and technological advancements across the globe. The market is anticipated to grow at a CAGR of 9.00% during the forecast period of 2025-2034, with the values likely to reach USD 1586.13 Million by 2034.
Base Year
Historical Year
Forecast Year
The growing demand for personalized medicine, advancement in biopharmaceuticals, and increased chronic diseases and genetic disorders, such as cancer and rare diseases, are the major factors driving the market growth.
The market is advancing with the introduction of innovations like gas-powered auto-injectors for high-viscosity biologics. In October 2023, Altaviz launched the AltaVISC framework, which provides a highly efficient and sustainable drug delivery system for next-generation therapies.
North America holds a major market share due to its strong healthcare structure and high investment in research and development. The region is growing rapidly by improving access to healthcare, which increases the disease prevalence and uses advanced drug delivery technologies.
Drug and gene delivery devices help control the delivery of drugs or genetic material in targeted body areas, leading to improved treatment outcomes. The drug and gene delivery devices increase patient compliance and optimize drug absorption while reducing side effects. The market for drug and gene delivery devices is focusing on the technology that allows targeted delivery of therapeutic agents, ensuring proper treatment. Increasing health needs, coupled with precision medicine and biotechnology advances, are driving market growth.
Increasing Prevalence of Chronic Diseases
The increase in chronic diseases like cancer, diabetes, and cardiovascular disease has spurred the demand for more advanced drug delivery systems. The Centers for Disease Control and Prevention reported that in the United States, an estimated 129 million people have at least one major chronic disease. These diseases often demand prolonged treatment where effective targeted, and efficient delivery devices can lead to better therapeutic benefits and minimal side effects, which enhances quality of life. As the global patient population increases, the need for effective delivery devices also increases.
Technological Advancements in Biotechnology to Boost Drug and Gene Delivery Devices Market Value
Advances in biotechnology, including CRISPR and gene editing, have significantly transformed gene delivery techniques. New drug delivery systems like nanoparticles, smart polymers, and biodegradable carriers have made it possible to release therapeutic agents precisely and in a controlled manner for enhanced efficacy. Such innovation is key to the development of gene-based therapies that would otherwise be impossible, opening the potential market.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Delivery Type
Market Breakup by Route of Administration
Market Breakup by Application
Market Breakup by Region
Segmentation Based on Route of Administration to Witness Substantial Growth
Based on route of administration, the market is segmented into oral, injectable, ocular, inhalation, nasal, transdermal, and topical. Among these, the injectable segment is expected to represent a significant share of the market. This is based on the high demand for injectable devices, especially for biologics and vaccines, which involve precise, controlled delivery to ensure the effectiveness of the drug. Apart from this, injectables also play a crucial role in chronic disease treatment and cancer therapy, which makes them dominant.
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds a large market share, mainly attributed to the strong healthcare structure, huge demand for better treatment options, and extensive investments in biotechnology and pharmaceuticals. The region's regulatory environment also propels innovation, which means that new drug delivery devices can quickly be commercialized. There is also an enormous patient population suffering from chronic diseases and genetic disorders, which catalyzes the growth of the market.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Shanghai Sunway Biotech contributes significantly to the market with advancements in gene therapy and immunotherapy solutions. Its GMP-certified oncolytic adenovirus production lines, combined with its manufacturing plasmids and viruses help to fill the increased demand for novel gene therapies and drug delivery systems, thereby expanding the market.
Pfizer is headquartered in New York, USA, and was established in 1849. It is one of the world's largest biopharmaceutical and drug delivery technologies, with key contributions to the gene delivery market. Notable products include its mRNA-based COVID-19 vaccines co-developed with BioNTech, as well as its groundbreaking partnership with Zipline to boost medicine delivery by drones in underprivileged areas.
Novartis has its headquarters in Basel, Switzerland, and was established in 1996. It is the global leader in gene and drug delivery technologies, mainly focusing on AAV-based therapies as well as CRISPR-based technologies. Some of its leading products are gene therapies for spinal muscular atrophy and other treatments for potential neurological and ophthalmological disorders.
Bayer AG is a German company from Leverkusen, founded in 1863. As a well-known leader in healthcare services, it specializes in modern cell and gene therapy options. Its key offerings to the gene delivery market encompass gene therapies for inherited diseases and acquired diseases, cellular therapies for damaged or otherwise malfunctioning cells, and genome editing tools.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Uniqure N.V., SiBiono GeneTech Co., Epeius Biotechnologies Corporation, F. Hoffmann-La Roche Ltd., and Becton, Dickinson and Company.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Delivery System |
|
| Breakup by Route of Administration |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share